Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Bronchogenic

Explore clinical trials studying Carcinoma, Bronchogenic. Study availability and eligibility vary by location and protocol.

5,226 public trials 1,176 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Bronchogenic trial results

Active, Not Recruiting

A Clinical Study to Evaluate the Efficacy and Safety of HLX26 (Anti-LAG-3 Monoclonal Antibody Injection) Combined With Serplulimab and Chemotherapy in Previously Untreated Advanced NSCLC Patients

NCT05787613

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • The Affiliated Hospital of Xuzhou Medical University Xuzhou, Jiangsu, China
  • Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China
  • Shanghai Chest Hospital Shanghai, Shanghai Municipality, China
View Trial Details
Active, Not Recruiting

Observational Prospective Study of Quality of Life in Unresectable TNM Stage III NSCLC (OBSTINATE)

NCT05049044

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Centre Hospitalier d'Aix en Provence Aix-en-Provence, France
  • CHU Amiens-Picardie Amiens, France
  • Centre Hospitalier Universitaire Angers, France
  • Centre Hospitalier d'Annecy Annecy, France
View all 34 locations
View Trial Details
Active, Not Recruiting

Study of Inupadenant (EOS100850) With Chemotherapy as Second Line Treatment for Nonsquamous Non-small Cell Lung Cancer

NCT05403385

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • Highlands Oncology Group Fayetteville, Arkansas, United States
  • H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
  • Algemeen Ziekenhuis Sint-Lucas Ghent, Belgium
  • Jessa Ziekenhuis Hasselt, Belgium
View all 21 locations
View Trial Details
Active, Not Recruiting

Phase I Study of Autologous CD8+ and CD4+ Engineered T Cell Receptor T Cells in Subjects With Advanced or Metastatic Solid Tumor

NCT06105021

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +22 more
Locations
  • USC Norris Comprehensive Los Angeles, California, United States
  • University of California Los Angeles Department of Medicine Los Angeles, California, United States
  • Yale New Haven Hospital New Haven, Connecticut, United States
  • Laura & Isaac Perlmutter Cancer Center at NYU Langone Health New York, United States
View Trial Details

Related conditions